Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer
Open Access
- 15 April 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (8), 3339-3346
- https://doi.org/10.1158/0008-5472.can-08-3440
Abstract
Androgen receptor (AR) plays a pivotal role in prostate cancer, primarily by regulating different gene expression programs elicited by androgen, which is important for cancer cell proliferation, survival, and differentiation. It is believed that the transcriptional function of AR is mediated largely by distinct nuclear coregulators. We report here the identification of ANCCA (also known as ATAD2), a new member of the AAA+ ATPase family proteins, as a novel AR coactivator. ANCCA interacts directly with AR and enhances its transcriptional activity, and is required for androgen-stimulated expression of a specific subgroup of genes including IGF1R, IRS-2, SGK1, and survivin. Upon androgen stimulation, ANCCA together with AR is recruited to the specific AR target genes. Suppression of ANCCA expression strongly inhibited the proliferation of androgen-responsive or androgen-independent, AR-positive prostate cancer cells and caused a significant increase of cellular apoptosis. Strikingly, the ANCCA gene itself, located at chromosome 8q24, is highly induced by androgen in androgen-dependent prostate cancer cells and xenograft tumors. Although ANCCA is hardly detected in normal human prostate tissue, high levels of ANCCA are found in hormone-independent prostate cancer cell lines, xenograft tumor, and a subset of prostate cancers with high Gleason scores. Together, these findings suggest that ANCCA plays an important role in prostate cancer by mediating specific AR functions in cancer cell survival and proliferation. The possession of ATPase and bromodomain by ANCCA makes it an attractive target for the development of therapeutics for the disease. [Cancer Res 2009;69(8):3339–46]Keywords
This publication has 41 references indexed in Scilit:
- Development of a Small-Molecule Serum- and Glucocorticoid-Regulated Kinase-1 Antagonist and Its Evaluation as a Prostate Cancer TherapeuticCancer Research, 2008
- Targeting the BAF57 SWI/SNF Subunit in Prostate Cancer: A Novel Platform to Control Androgen Receptor ActivityCancer Research, 2008
- ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERα, is required for coregulator occupancy and chromatin modificationProceedings of the National Academy of Sciences of the United States of America, 2007
- Cell- and gene-specific regulation of primary target genes by the androgen receptorGenes & Development, 2007
- Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptorProceedings of the National Academy of Sciences of the United States of America, 2007
- Genetic Ablation of the Amplified-in-Breast Cancer 1 Inhibits Spontaneous Prostate Cancer Progression in MiceCancer Research, 2007
- Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expressionNature, 2007
- Locus-Wide Chromatin Remodeling and Enhanced Androgen Receptor-Mediated Transcription in Recurrent Prostate Tumor CellsMolecular and Cellular Biology, 2006
- AAA+ proteins: have engine, will workNature Reviews Molecular Cell Biology, 2005
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003